Form 4: Catheter Precision CEO Converts Preferred Stock to Common
Insider Transaction Report
Catheter Precision's Chairman and CEO, David A. Jenkins, converted Series X Convertible Preferred Stock into common stock, increasing his direct and indirect common stock holdings.
Summary
- David A. Jenkins, Chairman of the Board and CEO of Catheter Precision, Inc. (VTAK), converted Series X Convertible Preferred Stock into common stock on December 5, 2025.
- He acquired 12,064 shares of common stock directly, bringing his total direct beneficial ownership to 13,799 shares.
- Through a partnership where he is the managing member, he indirectly acquired 30,844 shares of common stock, increasing the partnership's total indirect beneficial ownership to 34,579 shares.
- Through a charitable remainder unitrust where his spouse is the trustee, he indirectly acquired 98 shares of common stock, increasing the trust's total indirect beneficial ownership to 109 shares.
- The conversions resulted in the disposition of 2,292.339 shares of Series X Convertible Preferred Stock directly, 5,860.54 shares indirectly through the partnership, and 18.691 shares indirectly through the charitable trust, bringing all preferred stock holdings to zero.
- The conversion price for all transactions was $0, as is typical for such conversions.
Sentiment
Score: 7
Explanation: The conversion of preferred stock into common stock by the CEO, increasing his overall common stock holdings, is generally viewed as a positive indicator of management's confidence in the company's long-term prospects.
Positives
- The Chairman and CEO increased his direct and indirect beneficial ownership of common stock, which can signal confidence in the company's future performance.
- The conversion of preferred stock into common stock simplifies the capital structure by reducing the number of outstanding preferred shares.
Related Party Transactions
- Indirect beneficial ownership of common stock is held through a partnership where the reporting person is the managing member of the managing partner.
- Indirect beneficial ownership of common stock is held through a charitable remainder unitrust where the reporting person's spouse is the trustee.
Stakeholder Impact
- Shareholders may view the increased common stock ownership by the CEO as a positive signal of alignment between management and shareholder interests.
- The conversion of preferred stock to common stock could potentially increase the number of outstanding common shares, which might have a minor dilutive effect on existing common shareholders, though this is a standard capital structure event.
Key Dates
| Date | Description |
|---|---|
| 12/05/2025 | Date of the reported conversion transactions. |
| 12/08/2025 | Date the Form 4 was signed and filed. |
Keywords
Catheter Precision, VTAK, David A. Jenkins, Insider Transaction, Form 4, Common Stock, Preferred Stock Conversion, CEO Ownership, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.